cleerlyhealth.comHealthcare / Digital HealthFounded: 2016Funding to Date: $286.4MM
Cleerly, founded in 2016, is a digital healthcare company using AI to create a new standard of care for heart disease. The Cleerly platform is aiming to differentiate itself by using AI to measure plaque build-up in the heart’s arteries versus using indirect markers, like risk factors and symptoms of disease to help clinicians identify and define heart disease earlier and provide personalized treatment plans to patients.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/25/2022 | Series C | $230MM | $xx.xx | $624.64MM | T. Rowe Price Associates, Fidelity Management, Sands Capital, Piper Sandler, Heartland Healthcare Capital funds, Mirae Asset Capital, Peter Thiel, Breyer Capital, Novartis, Pura Vida Investments, Vensana Capital, LRVHealth, New Leaf Ventures, Cigna Ventures, DigiTx Partners | |
Price per Share
$xx.xx
Shares Outstanding
19,523,604
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
T. Rowe Price Associates, Fidelity Management, Sands Capital, Piper Sandler, Heartland Healthcare Capital funds, Mirae Asset Capital, Peter Thiel, Breyer Capital, Novartis, Pura Vida Investments, Vensana Capital, LRVHealth, New Leaf Ventures, Cigna Ventures, DigiTx Partners
|
||||||
06/21/2021 | Series B-1 | $16.8MM | $xx.xx | $114.1MM | Vensana Capital, LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures | |
Price per Share
$xx.xx
Shares Outstanding
3,853,457
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Vensana Capital, LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures
|
||||||
06/21/2021 | Series B | $28.1MM | $xx.xx | $114.1MM | Vensana Capital, LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures | |
Price per Share
$xx.xx
Shares Outstanding
8,408,926
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Vensana Capital, LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology, Cigna Ventures
|
||||||
08/10/2017 | Series A | $11.49MM | $xx.xx | $32.84MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,439,646
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
600.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|